PDCD1 and neoplasm: In mouse tumor models, RCL@Pd @CuZ + RT achieved >90% tumor growth inhibition compared with RT alone, and RCL@Pd @CuZ + RT + anti-PD-1 treatment maximally suppressed tumor growth (Li R. et al., 2024).